# Relationship Between Different Administration Regimens of Ceftazidime/Avibactam and Clinical Outcomes

> **NCT06528028** · PHASE4 · RECRUITING · sponsor: **The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School** · enrollment: 140 (estimated)

## Conditions studied

- Anti-Infective Agent

## Interventions

- **DRUG:** CAZ/AVI
- **DRUG:** CAZ/AVI

## Key facts

- **NCT ID:** NCT06528028
- **Lead sponsor:** The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-07-01
- **Primary completion:** 2025-06-30
- **Final completion:** 2025-07-30
- **Target enrollment:** 140 (ESTIMATED)
- **Last updated:** 2024-07-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06528028

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06528028, "Relationship Between Different Administration Regimens of Ceftazidime/Avibactam and Clinical Outcomes". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT06528028. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*